Community Blog Jack Ma Foundation Donates $2.15m to Australia Institute to Develop Virus Vaccine

Jack Ma Foundation Donates $2.15m to Australia Institute to Develop Virus Vaccine

The Jack Ma Foundation donated $2.15 million to the Peter Doherty Institute to accelerate research for a coronavirus vaccine.

Watch the webinar, Building a Real-Time Employee Health Solution with DataV, to learn how Alibaba Cloud is using DataV to cope with public health crisis by visualizing the health statuses of all its employees across the globe.


The Jack Ma Foundation has donated $2.15 million to accelerate the development of a coronavirus vaccine.

The foundation on Monday signed an agreement with the Peter Doherty Institute for Infection and Immunity in Australia to support the research and development of treatment options for the Covid-19 virus. A joint venture between the University of Melbourne and The Royal Melbourne Hospital, the Doherty Institute is a renowned center for scientific and medical research. In January, its scientists became the first to successfully grow the novel coronavirus in laboratory cell culture outside of China – an achievement that has been instrumental in aiding better understanding and diagnoses of the virus globally.

Funding from the Jack Ma Foundation will go toward developing an active vaccine platform, which would stimulate the production of antibodies in healthy individuals, as well as a passive platform that would transfer antibodies to non-immune individuals. The donation would also be used to ensure the efficacy, safety and readiness of the vaccine for first-phase human trials.

"While the path to creating a vaccine is complex, we have the expertise and infrastructure here at the Doherty Institute to take on this task, and now, thanks to the Jack Ma Foundation, the funding to accelerate this significant project," said Professor Sharon Lewin, director of the institute

Professor Christine Kilpatrick, CEO of the Royal Melbourne Hospital, also thanked the Jack Ma Foundation for its contribution to combating the virus that has so far infected more than 90,000 people since its detection in Wuhan, the capital of China's Hubei Province, last December.

"This important funding will help continue the efforts of our scientists in finding a vaccine and treatment for Covid-19 as part of the global effort to seek solutions to this worldwide health issue," he said.

The donation is part of an ongoing commitment from the Jack Ma Foundation to support vaccine development and other initiatives to tackle coronavirus. Last month, the foundation also awarded a $2.15 million grant to researchers at Columbia University to identify antiviral drugs and antibodies. The foundation has pledged a total of $14.4 million toward coronavirus-relief efforts.

While continuing to wage war against the worldwide outbreak, Alibaba Cloud will play its part and will do all it can to help others in their battles with the coronavirus. Learn how we can support your business continuity at https://www.alibabacloud.com/campaign/supports-your-business-anytime

Originally posted at: https://www.alizila.com/jack-ma-foundation-donates-2-15m-to-australia-institute-to-develop-virus-vaccine/

0 0 0
Share on

Alibaba Clouder

2,623 posts | 724 followers

You may also like


Alibaba Clouder

2,623 posts | 724 followers

Related Products

  • Retail Solution

    Alibaba Cloud enables digital retail transformation to fuel growth and realize an omnichannel customer experience throughout the consumer journey.

    Learn More
  • CT Image Analytics Solution

    This technology can assist realizing quantitative analysis, speeding up CT image analytics, avoiding errors caused by fatigue and adjusting treatment plans in time.

    Learn More
  • Sports Solution

    From immersive stadiums to data analytics, our sports solutions empower teams, athletes, and fans through the digital transformation of the sports industry

    Learn More
  • Business Mid-End Solution

    This solution provides you with an enterprise-level omnichannel digital platform that gets your procurement and sales onto the same platform to enhance business competitiveness.

    Learn More